SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2178747

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2178747

NAD+ Wellness Supplements Market Forecasts to 2034 - Global Analysis By Product Type, Product Form, Application, Distribution Channel, End User, Consumer Age Group, and By Geography

PUBLISHED:
PAGES: 300+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global NAD+ Wellness Supplements Market is accounted for $0.9 billion in 2026 and is expected to reach $2.4 billion by 2034 growing at a CAGR of 13.0% during the forecast period. NAD+ wellness supplements are ingestible nutritional products formulated to support cellular nicotinamide adenine dinucleotide levels, a coenzyme central to energy metabolism and cellular repair. They contain nicotinamide riboside, nicotinamide mononucleotide, niacin, and nicotinamide, which serve as precursors that the body converts into NAD+. These supplements are delivered as capsules, tablets, powders, gummies, and liquid drops, and are consumed daily by general wellness buyers, active adults, and older adults seeking cellular energy, healthy ageing, metabolic, recovery, and cognitive support.

Market Dynamics:

Driver:

Longevity Science Consumer Interest

Growing mainstream engagement with longevity research is driving demand for supplements positioned around cellular energy and healthy ageing. Media coverage of NAD+ decline with age, together with wellness influencer education, has introduced precursor compounds to premium supplement buyers. Brands publish clinical work on bioavailability and cellular markers, which strengthens credibility and supports premium pricing. This science-forward positioning expands shelf presence across specialty supplement retail and brand-owned e-commerce, thereby sustaining steady volume growth across developed markets.

Restraint:

Regulatory Classification Uncertainty

NAD+ precursor ingredients face varying regulatory classification across jurisdictions, with some authorities treating nicotinamide mononucleotide as a novel food requiring pre-market authorization while others permit sale as a dietary supplement. This inconsistency complicates cross-border distribution, forces reformulation for specific markets, and delays launches. Permissible claims are also restricted, since supplements cannot imply treatment of age-related conditions. These constraints increase compliance costs and slow category expansion, particularly in European and several Asian markets.

Opportunity:

Combination Longevity Formulations

Pairing NAD+ precursors with complementary actives such as resveratrol, spermidine, and urolithin A creates opportunity for brands to differentiate through multi-pathway longevity positioning. Combination formulas support higher price points and address consumers seeking consolidated daily regimens rather than single-ingredient products. Subscription models reinforce adherence and generate recurring revenue. As clinical substantiation improves and suppliers standardize precursor grades, combination formulations can capture premium demand across specialty retail and practitioner channels.

Threat:

Substitution by Established B Vitamins

Niacin and nicotinamide have long been available as inexpensive B-vitamin supplements, which reduces willingness among price-sensitive consumers to pay premiums for branded NAD+ precursor products. Many buyers perceive these commodity forms as functionally equivalent, particularly when clinical differentiation is not clearly communicated. If mainstream supplement brands add NAD+ positioning to existing B-vitamin lines at lower cost, specialist products may face margin pressure. Consequently, brands must substantiate bioavailability and cellular benefits to defend pricing.

Covid-19 Impact:

The pandemic heightened consumer interest in preventive health and cellular resilience, which extended into longevity supplements as buyers sought overall wellness support. During the crisis, e-commerce subscriptions for NAD+ precursors expanded rapidly while pharmacy footfall declined. Post-pandemic, sustained wellness habits and renewed interest in healthy ageing have reinforced demand, while brands strengthened clinical substantiation and expanded convenient formats such as gummies and liquid drops to improve adherence.

The Nicotinamide Riboside Supplements segment is expected to be the largest during the forecast period

The Nicotinamide Riboside Supplements segment is expected to account for the largest market share during the forecast period, due to its early commercial availability, extensive bioavailability research, and established consumer recognition within the NAD+ category. Nicotinamide riboside integrates readily into capsules and tablets, which supports broad distribution across specialty retail and e-commerce. As brands expand combination longevity formulas, this precursor remains the anchor ingredient that drives trial and repeat purchase, thereby sustaining leading revenue share across the market.

The Gummies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Gummies segment is predicted to witness the highest growth rate, driven by consumer preference for convenient, pleasant-tasting formats that improve daily adherence among younger buyers. Gummies reduce pill fatigue and support subscription models, while allowing brands to combine NAD+ precursors with complementary longevity actives in a single serving. As formulators improve active loading and stability in gummy matrices, launches multiply across pharmacy and e-commerce channels, making this the fastest-growing product form segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high supplement consumption, strong longevity research ecosystems, and widespread availability of NAD+ precursor products across specialty retail and online channels. The United States dominates regional revenue, supported by brands investing in clinical substantiation and convenient formats. Established dietary supplement pathways and active venture funding for wellness startups further reinforce North America's leading position in NAD+ wellness supplements.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly ageing populations, rising disposable incomes, and strong interest in healthy-ageing nutrition across Japan, China, South Korea, and India. Consumers readily adopt nicotinamide riboside and mononucleotide products, while local brands expand gummy and powder formats. Growing e-commerce penetration and nutrition clinic networks further support adoption, making Asia Pacific the fastest-growing regional market for NAD+ wellness supplements.

Key players in the market

Some of the key players in NAD+ Wellness Supplements Market include Nestle S.A., Danone S.A., Abbott Laboratories, Amway Corporation, Herbalife Ltd., USANA Health Sciences, Inc., Nature's Sunshine Products, Inc., Jamieson Wellness Inc., Haleon plc, Bayer AG, Glanbia plc, Blackmores Limited, NOW Health Group, Inc., Thorne HealthTech, Inc., Pharmavite LLC, and Swisse Wellness Pty Ltd.

Key Developments:

In October 2026, Thorne HealthTech, Inc. launched a nicotinamide riboside and resveratrol combination capsule supported by bioavailability testing, distributed through practitioner channels and brand-owned e-commerce across North American and European markets.

In September 2026, Haleon plc expanded its healthy-ageing portfolio with nicotinamide mononucleotide tablets and powders positioned for cellular energy support, targeting older adults through pharmacies and online marketplaces across Europe and Asia Pacific.

In August 2026, Blackmores Limited introduced NAD+ precursor gummies and liquid drops formulated for daily adherence, distributed through specialty retailers and e-commerce platforms with practitioner education programs across Australia and Southeast Asia.

Product Types Covered:

  • Nicotinamide Riboside Supplements
  • Nicotinamide Mononucleotide Supplements
  • Niacin Supplements
  • Nicotinamide Supplements

Product Forms Covered:

  • Capsules
  • Tablets
  • Powders
  • Gummies
  • Liquid Drops

Applications Covered:

  • Cellular Energy Support
  • Healthy Aging
  • Metabolic Wellness
  • Exercise Recovery
  • Cognitive Wellness

Distribution Channels Covered:

  • Brand-Owned E-Commerce
  • Online Marketplaces
  • Pharmacies and Drugstores
  • Specialty Retailers
  • Professional Channels

End Users Covered:

  • General Wellness Consumers
  • Active Adults
  • Older Adults
  • Nutrition Clinics
  • Wellness Practitioners

Consumer Age Groups Covered:

  • Adults Aged 18-39
  • Adults Aged 40-59
  • Adults Aged 60 and Above

Regions Covered:

North America

United States

Canada

Mexico

Europe

United Kingdom

Germany

France

Italy

Spain

Netherlands

Belgium

Sweden

Switzerland

Poland

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Thailand

Malaysia

Singapore

Vietnam

Rest of Asia Pacific

South America

Brazil

Argentina

Colombia

Chile

Peru

Rest of South America

Rest of the World (RoW)

Middle East

Saudi Arabia

United Arab Emirates

Qatar

Israel

Rest of Middle East

Africa

South Africa

Egypt

Morocco

Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling

Comprehensive profiling of additional market players (up to 3)

SWOT Analysis of key players (up to 3)

Regional Segmentation

Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)

Competitive Benchmarking

    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC41572

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global NAD+ Wellness Supplements Market, By Product Type

  • 5.1 Nicotinamide Riboside Supplements
  • 5.2 Nicotinamide Mononucleotide Supplements
  • 5.3 Niacin Supplements
  • 5.4 Nicotinamide Supplements

6 Global NAD+ Wellness Supplements Market, By Product Form

  • 6.1 Capsules
  • 6.2 Tablets
  • 6.3 Powders
  • 6.4 Gummies
  • 6.5 Liquid Drops

7 Global NAD+ Wellness Supplements Market, By Application

  • 7.1 Cellular Energy Support
  • 7.2 Healthy Aging
  • 7.3 Metabolic Wellness
  • 7.4 Exercise Recovery
  • 7.5 Cognitive Wellness

8 Global NAD+ Wellness Supplements Market, By Distribution Channel

  • 8.1 Brand-Owned E-Commerce
  • 8.2 Online Marketplaces
  • 8.3 Pharmacies and Drugstores
  • 8.4 Specialty Retailers
  • 8.5 Professional Channels

9 Global NAD+ Wellness Supplements Market, By End User

  • 9.1 General Wellness Consumers
  • 9.2 Active Adults
  • 9.3 Older Adults
  • 9.4 Nutrition Clinics
  • 9.5 Wellness Practitioners

10 Global NAD+ Wellness Supplements Market, By Consumer Age Group

  • 10.1 Adults Aged 18-39
  • 10.2 Adults Aged 40-59
  • 10.3 Adults Aged 60 and Above

11 Global NAD+ Wellness Supplements Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiling

  • 14.1 Nestle S.A.
  • 14.2 Danone S.A.
  • 14.3 Abbott Laboratories
  • 14.4 Amway Corporation
  • 14.5 Herbalife Ltd.
  • 14.6 USANA Health Sciences, Inc.
  • 14.7 Nature's Sunshine Products, Inc.
  • 14.8 Jamieson Wellness Inc.
  • 14.9 Haleon plc
  • 14.10 Bayer AG
  • 14.11 Glanbia plc
  • 14.12 Blackmores Limited
  • 14.13 NOW Health Group, Inc.
  • 14.14 Thorne HealthTech, Inc.
  • 14.15 Pharmavite LLC
  • 14.16 Swisse Wellness Pty Ltd.
Product Code: SMRC41572

List of Tables

  • Table 1 Global NAD+ Wellness Supplements Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global NAD+ Wellness Supplements Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global NAD+ Wellness Supplements Market Outlook, By Nicotinamide Riboside Supplements (2023-2034) ($MN)
  • Table 4 Global NAD+ Wellness Supplements Market Outlook, By Nicotinamide Mononucleotide Supplements (2023-2034) ($MN)
  • Table 5 Global NAD+ Wellness Supplements Market Outlook, By Niacin Supplements (2023-2034) ($MN)
  • Table 6 Global NAD+ Wellness Supplements Market Outlook, By Nicotinamide Supplements (2023-2034) ($MN)
  • Table 7 Global NAD+ Wellness Supplements Market Outlook, By Product Form (2023-2034) ($MN)
  • Table 8 Global NAD+ Wellness Supplements Market Outlook, By Capsules (2023-2034) ($MN)
  • Table 9 Global NAD+ Wellness Supplements Market Outlook, By Tablets (2023-2034) ($MN)
  • Table 10 Global NAD+ Wellness Supplements Market Outlook, By Powders (2023-2034) ($MN)
  • Table 11 Global NAD+ Wellness Supplements Market Outlook, By Gummies (2023-2034) ($MN)
  • Table 12 Global NAD+ Wellness Supplements Market Outlook, By Liquid Drops (2023-2034) ($MN)
  • Table 13 Global NAD+ Wellness Supplements Market Outlook, By Application (2023-2034) ($MN)
  • Table 14 Global NAD+ Wellness Supplements Market Outlook, By Cellular Energy Support (2023-2034) ($MN)
  • Table 15 Global NAD+ Wellness Supplements Market Outlook, By Healthy Aging (2023-2034) ($MN)
  • Table 16 Global NAD+ Wellness Supplements Market Outlook, By Metabolic Wellness (2023-2034) ($MN)
  • Table 17 Global NAD+ Wellness Supplements Market Outlook, By Exercise Recovery (2023-2034) ($MN)
  • Table 18 Global NAD+ Wellness Supplements Market Outlook, By Cognitive Wellness (2023-2034) ($MN)
  • Table 19 Global NAD+ Wellness Supplements Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 20 Global NAD+ Wellness Supplements Market Outlook, By Brand-Owned E-Commerce (2023-2034) ($MN)
  • Table 21 Global NAD+ Wellness Supplements Market Outlook, By Online Marketplaces (2023-2034) ($MN)
  • Table 22 Global NAD+ Wellness Supplements Market Outlook, By Pharmacies and Drugstores (2023-2034) ($MN)
  • Table 23 Global NAD+ Wellness Supplements Market Outlook, By Specialty Retailers (2023-2034) ($MN)
  • Table 24 Global NAD+ Wellness Supplements Market Outlook, By Professional Channels (2023-2034) ($MN)
  • Table 25 Global NAD+ Wellness Supplements Market Outlook, By End User (2023-2034) ($MN)
  • Table 26 Global NAD+ Wellness Supplements Market Outlook, By General Wellness Consumers (2023-2034) ($MN)
  • Table 27 Global NAD+ Wellness Supplements Market Outlook, By Active Adults (2023-2034) ($MN)
  • Table 28 Global NAD+ Wellness Supplements Market Outlook, By Older Adults (2023-2034) ($MN)
  • Table 29 Global NAD+ Wellness Supplements Market Outlook, By Nutrition Clinics (2023-2034) ($MN)
  • Table 30 Global NAD+ Wellness Supplements Market Outlook, By Wellness Practitioners (2023-2034) ($MN)
  • Table 31 Global NAD+ Wellness Supplements Market Outlook, By Consumer Age Group (2023-2034) ($MN)
  • Table 32 Global NAD+ Wellness Supplements Market Outlook, By Adults Aged 18-39 (2023-2034) ($MN)
  • Table 33 Global NAD+ Wellness Supplements Market Outlook, By Adults Aged 40-59 (2023-2034) ($MN)
  • Table 34 Global NAD+ Wellness Supplements Market Outlook, By Adults Aged 60 and Above (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!